Bitcoin may fall to a bottom price of 42,000-44,000. BTC is currently trading within the $61.4K mark. Jiang Zhuoer, a prominent Chinese Bitcoin miner and veteran market watcher, believes the current Bitcoin bear market could
Oil prices surged past the US$100 per barrel mark yesterday for the first time in nearly two years, sending shockwaves through global financial markets and renewing fears of sustained inflationary pressure on economies worldwide. The
The electric vehicle market has never moved at a leisurely pace, but anyone trying to keep up with developments over the past six months could be forgiven for feeling a touch of motion sickness. The
The months-long legal battle over the release of former President Joe Biden’s recordings from interviews with his memoir ghostwriter — obtained during special counsel Robert Hur’s classified documents investigation — came to an end on
CNBC's Jim Cramer has a blunt message for anyone trading artificial intelligence stocks with borrowed money: get out now. The Mad Money host warned Monday that the once-booming AI trade has grown increasingly fragile as
Bitcoin ETFs saw $526.64 million in net outflows. BTC is currently trading at around the $63.1K mark. U.S. spot Bitcoin ETFs have posted $526.64 million in net outflows between June 29 and July 2, extending
As part of the launch, GoMining is onboarding an initial set of up to 10 merchants and ecosystem partners. GoBTC Pay settles directly on Bitcoin while protecting user ownership and non-custody. GoMining is announcing the
Technology and artificial intelligence are no longer confined to Silicon Valley or a handful of mega-cap stocks. Instead, these innovations are spreading throughout the wider economy in ways that could reshape how investors think about
The high deserts of Nevada are seeing a sudden surge of activity as the federal government moves to secure domestic supplies of critical minerals. New directives from the Pentagon have effectively signaled a green light
The second quarter of 2026 proved to be a defining stretch for the biotech and pharmaceutical sectors, marked by a wave of consolidation, surprising clinical wins, and a regulatory environment that seems to be finding
